Hyperkrit 3% Inhalation Solution (4ml Each) is a sterile, preservative-free hypertonic saline solution containing Sodium Chloride at a concentration of 3% w/v, specifically formulated for inhalation therapy. It is primarily indicated for the management of respiratory conditions characterized by thick, tenacious mucus secretions, such as cystic fibrosis, chronic bronchitis, bronchiectasis, and other obstructive pulmonary diseases. The hypertonic nature of the solution facilitates osmotic hydration of airway secretions, thereby promoting mucociliary clearance and improving airway patency. Hyperkrit 3% Inhalation Solution is administered via nebulization, allowing direct delivery to the respiratory tract, enhancing its efficacy in loosening mucus and facilitating expectoration. The preservative-free formulation minimizes the risk of airway irritation and hypersensitivity reactions, making it suitable for repeated use in sensitive patient populations. It is recommended to be used under medical supervision, with dosage and frequency tailored according to individual patient needs and response. Caution is advised in patients with bronchospasm or hyperreactive airways; pre-treatment with a bronchodilator may be necessary. This product should be stored as per manufacturer guidelines to maintain sterility and efficacy. Hyperkrit 3% Inhalation Solution represents an effective adjunctive therapy in the management of mucus clearance in various pulmonary disorders.